Medicare Enrolled
Dr. Melissa Murphy, M.D.
Pain Medicine · Grapevine, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Murphy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Murphy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Murphy
Dr. Melissa Murphy is a pain medicine specialist in Grapevine, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Murphy performed 2,035 Medicare services across 1,545 unique beneficiaries.
Between the years covered by Open Payments, Dr. Murphy received a total of $487,137 from 17 pharmaceutical and/or device companies across 1026 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Murphy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 35% volume in TX
$487,137 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,035
Medicare services
Top 35% in TX for pain medicine
1,545
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~185 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
381 | $87 | $203 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $65 | $152 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
136 | $78 | $197 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
104 | $220 | $1,558 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
95 | $189 | $456 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
91 | $119 | $289 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
82 | $29 | $131 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
82 | $0 | $2 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
79 | $21 | $114 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
77 | $243 | $2,065 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
71 | $89 | $400 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
56 | $76 | $750 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
55 | $197 | $1,556 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
53 | $107 | $486 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
44 | $10 | $200 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
33 | $23 | $139 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
30 | $29 | $144 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
27 | $337 | $1,350 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
26 | $196 | $400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $41 | $96 |
| Hip joint contrast injection for imaging A contrast dye is injected into the hip joint to enhance visibility during medical imaging procedures. |
19 | $190 | $695 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $6 | $15 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
18 | $152 | $1,073 |
| Spinal neurostimulator generator insertion Surgical placement of a spinal neurostimulator generator or receiver device. |
18 | $152 | $1,090 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 16 | $360 | $713 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
16 | $34 | $87 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
13 | $187 | $1,586 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
13 | $65 | $512 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
12 | $9 | $75 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
11 | $63 | $318 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$487,137
Total received (2018-2024)
Avg $69,591/year across 7 years
Top 1% in TX for pain medicine
17
Companies
1,026
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$457,032 (93.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,666 (4.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,439 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$204,642
2023
$149,486
2022
$121,783
2021
$6,600
2020
$12
2019
$3,972
2018
$643
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$457,032
Pacira Pharmaceuticals Incorporated
$20,489
Relievant Medsystems, Inc.
$2,361
Abbott Laboratories
$2,128
MML US, Inc.
$1,726
Boston Scientific Corporation
$1,375
Stryker Corporation
$723
BOSTON SCIENTIFIC CORPORATION
$424
Medtronic USA, Inc.
$170
Stimwave Technologies Incorporated
$158
SPR Therapeutics, Inc
$138
Synergy Pharmaceuticals Inc
$124
Nalu Medical, Inc.
$99
Nevro Corp.
$63
GRT US Holding, Inc.
$58
Heron Therapeutics, Inc.
$56
Curonix LLC
$16
Top 3 companies account for 98.5% of total payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · APONVIE · DBS · ETERNA · Exparel · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · INTELLIS · INTELLIS ADAPTIVESTIM · INTERSTIM · IVS - VERTEBRAL AUGMENTATION PRODUCTS · Intracept · Iovera · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · MIDAS REX · N'VISION · Nalu Neurostimulation System · OSTEOCOOL RF ABLATION · OSTEOCOOL RF ABLATION SYSTEM · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRECISION · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Qutenza · RESTORE · RESTORESENSORSURESCAN · ReActiv8 · S-Series SCS Leads · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · SYNCHROMEDII · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w Receiver · Trulance · V-LOC 180 · VANTA ADAPTIVESTIM · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · ZYNRELEF · Zynrelef
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pain medicine in TX.
Equivalent to $23,938 per 100 Medicare services performed
Geographic Context
Pain medicines within 10 mi
96
Per 100K population
4.5
County median income
$81,905
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Murphy is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Murphy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Murphy performed 381 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Murphy receive payments from pharmaceutical companies?
Yes. Dr. Murphy received a total of $487,137 from 17 companies across 1,026 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Murphy's costs compare to other pain medicines in Grapevine?
Dr. Murphy's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Murphy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Grapevine
Browse pain medicines in Grapevine ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Pacira Pharmaceuticals Incorporated Payments to Doctors
See all physicians who received payments from Pacira Pharmaceuticals Incorporated.
By company
Relievant Medsystems, Inc. Payments to Doctors
See all physicians who received payments from Relievant Medsystems, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology